|
|||||
|
|
Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–2016 |
|
| Authors: | Shirin Ardeshirrouhanifard Huijun An Ravi K Goyal Mukaila A Raji Jodi B Segal G Caleb Alexander Hemalkumar B Mehta |
| Institution: | 1. Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA;2. College of Pharmacy, University of Houston, Houston, Texas, USA RTI Health Solutions, Durham, North Carolina, USA;3. Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas, USA;4. Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA;5. Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA |
| Abstract: | |
| Keywords: | anticoagulation atrial fibrillation cancer direct-acting oral anticoagulants |